• Publishes critical reviews of broad interest on the treatment of neurologic disorders by renowned experts.
  • Covers emerging treatments for neurologic disorders.
  • Publishes cutting edge original translational research in unmet medical needs for diseases of the nervous system.
  • Explores the molecular underpinnings of neurologic diseases as rationale for targeted therapies.
  • Provides a platform for publishing points-of-view by key opinion leaders on current hot topics.

Journal information

Editor-in-Chief
  • Maral Mouradian
Publishing model
Hybrid. Open Access options available

Journal metrics

5.552 (2018)
Impact factor
5.720 (2018)
Five year impact factor
24 days
Submission to first decision
91 days
Submission to acceptance
508,580 (2019)
Downloads

Latest issue

Volume 17

Issue 1, January 2020

Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use Disorders

Latest articles

This journal has 93 open access articles

Journal updates

  • Announcement: COVID-19 impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Future Theme Issues

    January 2020
    Neurobiological Targets in Translational Addiction Research

    Guest Editors:  Jesse Schank (U-GA) and Carolina Haas-Koffler (Brown)

    April 2020
    Neurocritical Care:  Bench to Bedside and Back

    Guest Editors:  Claude Hemphill (UCSF) and Michael James (Duke) 

    July 2020
    Aligning New Approaches to Accelerate the Development of Analgesic Therapies

    Guest Editors: Christine Sang (Brigham) and William Schmidt (NorthStar Consulting)

    October 2020
    Therapeutic Advances in Movement Disorders

    Guest Editors:  Caroline Tanner and Jill Ostrem (UCSF)

View all updates

Societies, partners and affiliations

Subscribe

eJournal
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

Advertisement

About this journal

Electronic ISSN
1878-7479
Print ISSN
1933-7213
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Current Contents/ Life Sciences
  4. Current Contents/Clinical Medicine
  5. EBSCO Biomedical Reference Collection
  6. EBSCO CINAHL
  7. EBSCO Discovery Service
  8. EMBASE
  9. Gale
  10. Gale Academic OneFile
  11. Gale InfoTrac
  12. Google Scholar
  13. Institute of Scientific and Technical Information of China
  14. Japanese Science and Technology Agency (JST)
  15. Journal Citation Reports/Science Edition
  16. Medline
  17. Meta
  18. Naver
  19. OCLC WorldCat Discovery Service
  20. ProQuest Biological Science Database
  21. ProQuest Central
  22. ProQuest Health & Medical Collection
  23. ProQuest Health Research Premium Collection
  24. ProQuest Medical Database
  25. ProQuest Natural Science Collection
  26. ProQuest Neurosciences Abstracts
  27. ProQuest Nursing & Allied Health Database
  28. ProQuest Pharma Collection
  29. ProQuest Psychology Database
  30. ProQuest SciTech Premium Collection
  31. ProQuest-ExLibris Primo
  32. ProQuest-ExLibris Summon
  33. Psyndex
  34. PubMedCentral
  35. Reaxys
  36. SCImago
  37. SCOPUS
  38. Science Citation Index Expanded (SciSearch)
Copyright information

Rights and permissions

Springer policies

© The American Society for Experimental NeuroTherapeutics, Inc.